Bromide

Bromide

SCHEMBL1045353

C=CCn1cc[n+](CC=C)c1.[Br-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL87311 0.98 ALDH1A1 (0.30) ALDH1A1GAA
Bromide SCHEMBL30218911 0.96
SCHEMBL19857303 0.96
Iodide SCHEMBL2341576 0.96 ALDH1A1 (0.33) ALDH1A1GAA
Water SCHEMBL15361762 0.96
Hydrochloric Acid SCHEMBL572630 0.96
SCHEMBL7551318 0.91 ALDH1A1 (0.30) ALDH1A1GAA
SCHEMBL3800556 0.91
SCHEMBL17240887 0.91
SCHEMBL4246783 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140319503-A1 SEMICONDUCTING POLYMER UNIV UNITED ARAB EMIRATES (AE) 2014-10-30 US claimed
US-8796673-B2 Semiconducting polymer UNITED ARAB EMIRATES UNIVERSITY (AE) 2014-08-05 US claimed
CN-103380503-A Semiconducting polymer UNIV UNITED ARAB EMIRATES 2013-10-30 CN claimed
US-20120211732-A1 SEMICONDUCTING POLYMER UNITED ARAB EMIRATES UNIVERSITY (AE) 2012-08-23 US claimed
US-20100261945-A1 METHOD OF SEPARATING AROMATIC COMPOUND FROM MIXTURE CONTAINING AROMATIC COMPOUND AND ALIPHATIC COMPOUND SAMSUNG ENGINEERING CO., LTD. (KR) 2010-10-14 US claimed
US-12506156-B2 Current collector for lithium battery HONDA MOTOR CO., LTD. (JP) 2025-12-23 US disclosed
US-12266795-B2 Positive electrode active material for sodium-ion secondary battery NIPPON ELECTRIC GLASS CO., LTD. (JP) 2025-04-01 US disclosed
US-20250029983-A1 CARBON FOAMS, DOPED CARBON COMPOSITES, PROCESSES FOR FABRICATING CARBON FOAMS AND DOPED CARBON COMPOSITES, AND USES THEREOF UNIVERSITY OF WYOMING 2025-01-23 US disclosed
US-20250006922-A1 SODIUM ION SECONDARY BATTERY NIPPON ELECTRIC GLASS CO., LTD. (JP) 2025-01-02 US disclosed
US-12176522-B2 Carbon foams, doped carbon composites, processes for fabricating carbon foams and doped carbon composites, and uses thereof UNIVERSITY OF WYOMING (US) 2024-12-24 US disclosed
CN-118943362-A Positive electrode active material for sodium ion secondary battery 日本电气硝子株式会社 2024-11-12 CN disclosed
EP-4439765-A1 SODIUM ION SECONDARY BATTERY Nippon Electric Glass Co., Ltd. (JP) 2024-10-02 EP disclosed
EP-2249832-A1 METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS Agency for Science, Technology And Research (SG) 2010-11-17 EP disclosed
US-20100261945-A1 METHOD OF SEPARATING AROMATIC COMPOUND FROM MIXTURE CONTAINING AROMATIC COMPOUND AND ALIPHATIC COMPOUND SAMSUNG ENGINEERING CO., LTD. (KR) 2010-10-14 US disclosed
WO-2009123569-A1 METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2009-10-08 WO disclosed
WO-2009096905-A1 METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2009-08-06 WO disclosed
US-7517999-B2 needs no complicated operations for dissolution and has excellent handleability and a high ionic conductivity, electrolytes; 1-butyl-3-allylimidazolium bromide KANTO KAGAKU KABUSHIKI KAISHA (JP) 2009-04-14 US disclosed
US-20070191612-A1 Needs no complicated operations for dissolution and has excellent handleability and a high ionic conductivity, electrolytes; 1-butyl-3-allylimidazolium bromide HIROYUKI OHNO (JP) 2007-08-16 US disclosed
CN-1922152-A Novel imidazolium compound KANTO KAGAKU (JP) 2007-02-28 CN disclosed
EP-1721900-A1 NOVEL IMIDAZOLIUM COMPOUND Kanto Kagaku Kabushiki Kaisha (JP) 2006-11-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191612-A1 Needs no complicated operations for dissolution and has excellent handleability and a high ionic conductivity, electrolytes; 1-butyl-3-allylimidazolium bromide SLC26A3, KCNJ11, SLC26A4 ALDH1A1 538/4885GAA 3480/4885
US-20100261945-A1 METHOD OF SEPARATING AROMATIC COMPOUND FROM MIXTURE CONTAINING AROMATIC COMPOUND AND ALIPHATIC COMPOUND AHR, ALK, PAH ALDH1A1 2125/4885GAA 2891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.